Filing Details

Accession Number:
0001140361-17-025045
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-14 19:39:02
Reporting Period:
2017-06-12
Filing Date:
2017-06-14
Accepted Time:
2017-06-14 19:39:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1301501 Achaogen Inc AKAO Pharmaceutical Preparations (2834) 680533693
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1678984 Tobin Schilke C/O Achaogen, Inc.
1 Tower Place, Suite 300
South San Francisco CA 94080
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-06-12 2,066 $21.53 40,119 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") of the Issuer.
  2. Includes (i) 32,925 RSUs and (ii) 2,640 shares acquired under the issuer's Employee Stock Purchase Plan on May 31, 2017.